A study of vestibular schwannomas using positron emission tomography and monoclonal antibody Ki-67

American Journal of Otology

Volumn 19, Issue 6, 1998, Pages 840-845

  Chen, Joseph M ^a,b   Houle, Sylvain ^a   Ang, Lee C ^b   Commins, Dermot ^a   Allan, Katherine ^b   Nedzelski, Julian ^a   Rowed, David ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Ki 67; Positron emission Tomography; Vestibular schwannoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; NEURILEMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR GROWTH; VESTIBULAR DISORDER;

ADULT; AGED; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MITOTIC INDEX; NEUROMA, ACOUSTIC; PILOT PROJECTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031734441     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Henschen F, Lundburg T. The relationship between the clinical course and the morphologic picture of acoustic neuroma. Acta Otolaryngol (Stockh) 1954;116:121-6.
2. Nedzelski JM, Canter RJ, Kassel EE, et al. Is no treatment good treatment in the management of acoustic neuromas in the elderly? Laryngoscope 1986;96:825-9.
3. Strasnick B, Glasscock ME, Haynes, et al. The natural history of untreated acoustic neuromas. Laryngoscope 1994;104:1115-9.
4. Bederson JB, von Ammon K, Wichmann WW, et al. Conservative treatment of patients with acoustic tumors. Neurosurgery 1991;28:646-9.
5. Thomsen J, Tos M. Acoustic neuroma: clinical aspects, audiovestibular assessment, diagnostic delay, and growth rate. Am J Otol 1990;11:12-9.
6. Boberly K, Fulham MJ, Brooks RA, et al. PET-fluorodeoxyglucose of cranial and spinal neuromas. J Nucl Med 1992;33:1931-4.
7. Charabi S, Lassen NA, Thomsen J, et al. Thallium chloride 201-T1 combined with single photon emission computed tomography (SPECT) in the evaluation of vestibular schwannoma growth. Acta Otolaryngol (Stockh) 1997;117:35-40.
8. Kahn D, Follett KA, Bushnell DL, et al. Diagnosis of recurrent brain tumor: value of 201T1 SPECT vs 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994;163:1459-65.
9. Raichle ME. Positron emission tomography. In: Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Schuller DE, eds. Otolaryngology Head and Neck Surgery-Update I. St. Louis: Mosby Co., 1989:45-55.
10. Rasmussen N, Tribukait B, Thomsen J, et al. Implication of DNA characterization of human acoustic neuromas. Acta Otolaryngol (Stockh) 1984;(Suppl)406:278-81.
11. Kesterson L, Shelton C, Dressler L, et al. Clinical behaviour of acoustic tumors. Arch Otolaryngol Head Neck Surg 1993;119: 269-71.
12. Burger PC, Shibata T, Kleihues P. The use of monoclonal antibody Ki-67 in the identification of proliferating cells: application of surgical neuropathology. Am J Surg Pathol 1986;10:611-7.
13. Lesser THJ, Janzer RC, Kleihues P, et al. Clinical growth rate of acoustic schwannomas-correlation with the growth fraction as defined by the monoclonal antibody Ki-67. Skull Base Surg 1991;1:11-5.
14. Charabi S, Engel P, Charabi B, et al. Growth of vestibular schwannoma: in situ model employing the monoclonal antibody Ki-67 and DNA flow cytometry. Am J Otol 1996;17:301-6.
15. Szeremeta W, Monsell EM, Rock JP, et al. Proliferation indices of vestibular schwannomas by Ki-67 and proliferating cell nuclear antigen. Am J Otol 1995;16:616-9.
16. Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
17. Kirsh WM, Schultz D, Van Buskirk J, et al. Anaerobic energy metabolism in brain tumors. Prog Exp Tumor Res 1972;17: 163-7.
18. Patronas NJ, Di Chiro G, Kufka C, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985;62:816-22.
19. Erikson K, Lilja A, Bergstrom A, et al. Positron emission tomography with (11-C methyl)-L-methionine, (11-C)-D-glucose and (G8-Ga) EDTA in supratentorial tumors. J Comput Assist Tomogr 1985;9:683-9.
20. Heiss WD, Beil C, Herholz K, et al. Measurement of glucose metabolism. In: Atlas of positron emission tomography of the brain. New York: Springer, 1985:47-93.
21. Di Chiro G, Hatazawa J, Katz DA, et al. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. Radiology 1987;164:521-6.